Coronavirus vaccine development: from SARS and MERS to COVID-19

SARS-CoV-2 is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19). It has been the most challenging pandemic in this century...

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020

Pfizer-BioNTech COVID-19 vaccine has reported 4,393 (0.2%) adverse events in the Cases of anaphylaxis were determined to be rare but still under inve...

COVID-19 vaccine research and development: ethical issues

The achievements of vaccine research and development bring a hope to our societies that we may cope with the COVID-19 pandemic. There are two aspects...

Vaccine Hesitancy and Demand for Immunization in Eastern Europe and Central Asia: Implications for the Region and Beyond

Vaccine hesitancy has become a growing concern globally. It calls into question the safety and efficacy of vaccines. It threatens the progress made in...

COVID-19 vaccines: Global challenges and prospects forum recommendations

The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was held...

COVID-19 vaccines: Global challenges and prospects forum recommendations

The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was held...